Johnson Matthey sees profit at top end of analyst view; reviews health unit

By Reuters6 days ago

AD

April 8 (Reuters) - Chemicals maker Johnson Matthey JMAT.L said on Thursday it has started a strategic review of its health business and forecast annual profit at the top end of market expectations thanks to a recovery in the automotive market.

A company-compiled consensus of analyst expectations shows full-year underlying operating profit between 405 million pounds and 502 million pounds, the company, one of Europe's leading producers of autocatalysts said.

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shailesh Kuber)

Continue read on nasdaq.com